|
Ted Gastineau is the CEO and co-founder of ICON Medical Imaging (Beacon Bioscience).a leading specialist CRO in the medical imaging field. In 2004, ICON acquired a 70% interest in Beacon.
Prior to Beacon, Ted co-founded Intelligent Imaging, a research company specializing in imaging, which was acquired by Quintiles in 1997. From 1997-2000 he served as Senior Vice-President and Business Unit Head within Quintiles. Ted has more than 15 years in imaging for drug development and has worked closely with industry, FDA, and academia to establish best practices in place today.
Ted has held academic positions with the University of Maryland, John Hopkins School of Medicine, Cambridge University and the Smithsonian Institution. He holds a bachelors degree in Zoology and pursued PhD in neurophysiology prior to founding Intelligent Imaging. | 